Insception Biosciences
Insception is the largest cord blood program in Canada with over 39,000 cord blood units banked. Insception is owned by Argosy Partners, Mount Sinai Hospital, management and its scientific founders. By partnering with leading Canadian medical facilities such as Toronto's Mount Sinai and the Scarborough Hospitals, Insception continues to work closely with Canada's leading healthcare providers. The Insception Cord Blood Program is able to provide every Canadian family with security, state of the art processing and storage, financial stability and long term professional governance.
Tech Stack (30 technologies)
Frequently Asked Questions
What technologies does Insception Biosciences use?+
Insception Biosciences uses 30 technologies including Divi, Facebook Pixel, Google Analytics.
What industry is Insception Biosciences in?+
Insception Biosciences operates in the Biotechnology industry.
Where is Insception Biosciences based?+
Insception Biosciences is headquartered in Canada.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: July 2026